Impurity Product Detail

Bimatoprost Acid

Chemical Properties and Information

Product Code: CS-T-06501 Impurity
Bimatoprost Acid
API Family
Bimatoprost
Product Code
CS-T-06501

Bimatoprost Acid

Bimatoprost Impurity
Stock Status: In Stock
Live

CAT No.
CS-T-06501
CAS No.
38344-08-0
Molecular Formula
C₂₃H₃₂O₅
Molecular Weight
388.50
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
38344-08-0
Product Code
CS-T-06501
M.F.
C₂₃H₃₂O₅
M.W.
388.50
Smiles
O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O
Category
Impurity
API Family
Bimatoprost
Storage Condition
Store at freezer (-20°C) for long term storage
IUPAC Name
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid
References
"Balapure, A,K, et al,: Biochem, Pharmacol,, 38, 2375 (1989); Hellberg, M,R, et al,: J, Ocular Pharmacol, Ther,, 19, 97 (2003); Krishna, P,M, et al,: J, Pharm, res,, 4, 2381 (2011); "
Synonyms
Not available
Application Notes
Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost .Bimatoprost Acid is a metabolically stable analog of PGF2a and is a potent agonist for the FP receptor.;Impurity in commercial preparations of Bimatoprost
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost .Bimatoprost Acid is a metabolically stable analog of PGF2a and is a potent agonist for the FP receptor.;Impurity in commercial preparations of Bimatoprost
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.